The Vaccines Development Conference September 23-25 2009 Boston MA, USA
The Vaccines Development Conference brings together scientists and industry experts from pharma, biotech, academia and government to share what’s working and not working for them, and to address your key vaccine development challenges and questions.
- Novel Adjuvant Development: Hear current advances in novel adjuvants with discussions and case studies from National Cancer Institute, NIH, Big DNA, Datamonitor and Vical
- Thermostability: Learn formulation strategies from Program for Appropriate Technology in Health (PATH), Stabilitech, and Integrity Bio to improve vaccine stability and enhance access
- Delivery: Uncover the latest vaccine delivery advances and the stabilization, potency testing, and formulation developments associated with needle-free delivery with case studies from Georgia Tech, Aktiv-Dry/University of Colorado, and Program for Appropriate Technology in Health (PATH)
- Analytical Testing: Master the most appropriate and efficient analytical testing methods and techniques to evaluate and analyze your vaccines with case studies from Wyeth Vaccines and Genzyme
- Potency and Immunogenicity Testing: Strategize with Acambis/Sanofi-Pasteur, VirXsys, and BigDNA to uncover strategies for improved vaccine assessment.
- Manufacturing & Process Development: Tap into efficient and comparable manufacturing, scale up, and tech transfer approaches from Immunovaccine Technologies, BigDNA, and NIH.
